Counterpoint Mutual Funds LLC Purchases Shares of 15,523 Encompass Health Corporation $EHC

Key Points

• Counterpoint Mutual Funds LLC acquired 15,523 shares of Encompass Health Corporation, amounting to approximately $1.9 million, during the second quarter.
• Encompass Health reported $1.40 EPS for the last quarter, exceeding expectations and showing a 12% year-over-year revenue growth with total revenue of $1.46 billion.
• The company announced an increase in its quarterly dividend to $0.19 per share, reflecting a yield of 0.6% and marking an increase from the previous dividend of $0.17.

Counterpoint Mutual Funds LLC purchased a new stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 15,523 shares of the company's stock, valued at approximately $1,904,000.

Several other large investors have also added to or reduced their stakes in the company. OneDigital Investment Advisors LLC purchased a new stake in shares of Encompass Health in the first quarter worth about $263,000. GAMMA Investing LLC boosted its stake in shares of Encompass Health by 21.5% in the first quarter. GAMMA Investing LLC now owns 2,366 shares of the company's stock worth $240,000 after buying an additional 419 shares during the last quarter. Sequoia Financial Advisors LLC boosted its stake in shares of Encompass Health by 6.7% in the first quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company's stock worth $276,000 after buying an additional 172 shares during the last quarter. Cambridge Investment Research Advisors Inc. boosted its stake in shares of Encompass Health by 30.1% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 9,597 shares of the company's stock worth $972,000 after buying an additional 2,218 shares during the last quarter. Finally, Fifth Third Bancorp boosted its stake in shares of Encompass Health by 88.7% in the first quarter. Fifth Third Bancorp now owns 4,290 shares of the company's stock worth $434,000 after buying an additional 2,017 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company's stock.

Encompass Health Price Performance

NYSE:EHC opened at $126.12 on Tuesday. Encompass Health Corporation has a one year low of $87.85 and a one year high of $127.15. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The stock has a market cap of $12.70 billion, a PE ratio of 24.68, a P/E/G ratio of 2.17 and a beta of 0.92. The stock has a 50 day moving average price of $118.25 and a 200 day moving average price of $113.99.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The company reported $1.40 EPS for the quarter, beating the consensus estimate of $1.20 by $0.20. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The firm had revenue of $1.46 billion during the quarter, compared to analysts' expectations of $1.43 billion. During the same quarter last year, the firm earned $1.11 earnings per share. The business's revenue for the quarter was up 12.0% on a year-over-year basis. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Equities research analysts expect that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a yield of 0.6%. This is a positive change from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date of this dividend is Wednesday, October 1st. Encompass Health's payout ratio is 13.31%.

Analyst Ratings Changes

EHC has been the topic of a number of recent research reports. Bank of America upped their target price on Encompass Health from $145.00 to $160.00 and gave the stock a "buy" rating in a research note on Wednesday, September 10th. UBS Group upped their target price on Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Truist Financial increased their price target on Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a research report on Thursday, August 14th. Wall Street Zen downgraded Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. Finally, Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research report on Thursday, June 5th. One research analyst has rated the stock with a Strong Buy rating and seven have assigned a Buy rating to the company's stock. According to MarketBeat.com, Encompass Health currently has an average rating of "Buy" and a consensus price target of $138.43.

Insider Transactions at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the firm's stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the sale, the executive vice president owned 18,846 shares of the company's stock, valued at $2,329,177.14. This trade represents a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.10% of the stock is currently owned by company insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.